StockData
RDHLNasdaqPharmaceutical Preparations

RedHill Biopharma Ltd.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 27, 2026
$0.50+0.02 (+4.39%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
0.0%
0M of 50.92B shares
Institutional holders
14
2 new, 4 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
0 buys · 2 sales
Net bought $0

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
SC-Sigma Global Partners, LP508,7239.90%13G (passive)Dec 19, 2025
Alumni Capital LP369,3739.99%13G (passive)Jun 20, 2025
Hal Mintz––13G (passive) amendmentDec 31, 2023

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of RDHLValueChange% of portfolio
Yorkville Advisors Global, LP122,1310.00%$106.68K−228,7390.12%
Gagnon Securities LLC88,4050.00%$74.70K–0.01%
Citadel Advisors LLC65,3210.00%$55.20K+44,6480.00%
Rhumbline Advisers13,7550.00%$11.62K+8,6390.00%
Lido Advisors, LLC11,0090.00%$9.30KNew0.00%
GAMMA Investing LLC6,9570.00%$5.88K+2730.00%
Citigroup Inc4,3780.00%$3.70KNew0.00%
Federation des caisses Desjardins du Quebec3,3880.00%$2.86K–0.00%
Royal Bank of Canada3510.00%$0+3500.00%
UBS Group AG1000.00%$85−7260.00%
SBI Securities Co., Ltd.150.00%$13+110.00%
Smartleaf Asset Management LLC50.00%$4–0.00%
Vermillion Wealth Management, Inc.20.00%$2–0.00%
Morgan Stanley10.00%$1–0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026140M0.0%2 / 52 / 40M0M
Q1 2026161M0.0%3 / 51 / 40M0M
Q4 2025170M0.0%4 / 33 / 10M0M
Q3 2025140M0.0%4 / 05 / 20M0M
Q2 2025120M0.0%1 / 53 / 10M0M
Q1 2025120M0.0%2 / 33 / 10M0M
Q4 2024110M0.0%3 / 41 / 20M0M
Q3 2024100M0.0%10 / 00 / 00M0M

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Dror Ben-AsherChief Executive Officer, Director441,350,0000.87%Mar 18, 2026
Rick D. ScruggsChief Commercial Officer, Director312,500,0000.61%Mar 18, 2026
Gilead RadayChief Operating Officer218,780,0000.43%Jul 13, 2026
Adi FrishChief Corp & BD Officer276,810,0000.54%Mar 18, 2026
Guy Joel GoldbergChief Business Officer305,720,0000.60%Mar 18, 2026
Razi IngberChief Financial Officer277,560,0000.55%Mar 18, 2026
Ofer TsimchiDirector146,250,0000.29%Mar 19, 2026
Kenneth ReedDirector105,200,0000.21%Mar 18, 2026
Shmuel CabillyDirector105,200,0000.21%Mar 18, 2026
Roni MamlukDirector103,500,0000.20%Mar 18, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Gilead Raday
Chief Operating Officer
Jul 10, 2026Sale−14,130,000––218,780,000
Gilead Raday
Chief Operating Officer
Apr 6, 2026Sale−15,740,000––261,060,000

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.